Monoclonal Antibody Treatment for COVID-19
Monoclonal antibodies are laboratory-made proteins that mimic natural antibodies’ ability to fight viruses such as COVID-19. Clinical trials have shown fewer COVID-19-related hospitalizations or emergency room visits and a decrease in the amount of virus in an infected person’s blood in patients at high risk for developing severe COVID-19 symptoms.
You may be eligible for monoclonal antibody treatment if you recently tested positive for COVID-19, or were recently exposed, and are at a greater risk of developing severe COVID-19 symptoms.
Not sure if you qualify? Answer the following below to find out:
- Do you weigh more than 88 pounds and are you older than 12?
- Do you have any of these health conditions or characteristics?
- Overweight (BMI over 25)
- Chronic kidney disease
- Diabetes (Type 1 or Type 2)
- Weakened immune system
- Currently receiving immunosuppressive treatment
- Cardiovascular disease/hypertension
- Chronic lung disease
- Sickle cell disease
- Neurodevelopmental disorders
- Medical-related technological dependence
- Have you received a positive COVID-19 test result in the last 10 days? After 10 days it is too late to start this treatment.
If you answered YES to the above, you may be eligible for monoclonal antibody treatment. A doctor will need to confirm if you qualify.
If you have no symptoms, but have been exposed in the past four days to a known or suspected case of COVID-19 and are in one of the following categories, you may be eligible for treatment to prevent COVID-19:
- Are not fully vaccinated
- Are vaccinated but not expected to have an adequate immune response to the vaccine
- Are in a congregate living situation such as a nursing home or prison
Please note that monoclonal antibody treatment is not a substitute for vaccination.